Skip to main content
SpringerLink
Log in

Conflicting Results on the Efficacy of Enteral Nutrition During Infliximab Maintenance Therapy for Crohn’s Disease Are Correct

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hirai F, Ishihara H, Yada S, et al. Effectiveness of concomitant enteral nutrition therapy and infliximab for maintenance treatment of Crohn’s disease in adults. Dig Dis Sci. 2013;58:1329–1334.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K. Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn’s disease. J Gastroenterol. 2010;45:24–29.

    Article  CAS  PubMed  Google Scholar 

  3. Yamamoto T, Shiraki M. Efficacy of enteral nutrition during infliximab maintenance therapy in patients with Crohn’s disease. Dig Dis Sci. 2013;58:1802–1803.

    Article  PubMed  Google Scholar 

  4. Hirai F. Reply. Dig Dis Sci. 2013;58:1803.

    Article  PubMed  Google Scholar 

  5. Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012;61:1619–1635.

    Article  CAS  PubMed  Google Scholar 

  6. D’Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomized trial. Lancet. 2008;371:660–667.

    Article  PubMed  Google Scholar 

  7. Rubin DT, Uluscu O, Sederman R. Response to biologic therapy in Crohn’s disease is improved with early treatment: an analysis of health claims data. Inflamm Bowel Dis. 2012;18:2225–2231.

    Article  PubMed  Google Scholar 

  8. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial. Lancet. 2002;359:1541–1549.

    Article  CAS  PubMed  Google Scholar 

  9. Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn’s disease: a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24:1333–1340.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Akita City Hospital, 4-30, Matsuoka-machi, Kawamoto, Akita, 010-0933, Japan

    Mitsuro Chiba, Tsuyotoshi Tsuji & Masafumi Komatsu

Authors
  1. Mitsuro Chiba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tsuyotoshi Tsuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masafumi Komatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuro Chiba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiba, M., Tsuji, T. & Komatsu, M. Conflicting Results on the Efficacy of Enteral Nutrition During Infliximab Maintenance Therapy for Crohn’s Disease Are Correct. Dig Dis Sci 59, 227–228 (2014). https://doi.org/10.1007/s10620-013-2954-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2954-9

Keywords

Search

Navigation